RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • September 10th, 2015 • Gensight Biologics S.A. • Biological products, (no disgnostic substances) • Basel-Stadt
Contract Type FiledSeptember 10th, 2015 Company Industry JurisdictionThis Research Collaboration Agreement (the “Agreement”) having an Effective Date of March 1st, 2014, is made between the Friedrich Miescher Institute for Biomedical Research (“FMI”) located at Maulbeerstrasse 66, 4058 Basel, Switzerland, (Principal Investigator Dr. Botond Roska), and GenSight Biologics, located at 89 Rue du Fbg Saint Antoine, 75011 Paris, France (“GenSight”), (Principal Investigator Dr. Didier Pruneau), under the following terms and conditions.
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • July 7th, 2015 • Gensight Biologics • Biological products, (no disgnostic substances) • Basel-Stadt
Contract Type FiledJuly 7th, 2015 Company Industry JurisdictionThis Research Collaboration Agreement (the “Agreement”) having an Effective Date of March 1st, 2014, is made between the Friedrich Miescher Institute for Biomedical Research (“FMI”) located at Maulbeerstrasse 66, 4058 Basel, Switzerland, (Principal Investigator Dr. Botond Roska), and GenSight Biologics, located at 89 Rue du Fbg Saint Antoine, 75011 Paris, France (“GenSight”), (Principal Investigator Dr. Didier Pruneau), under the following terms and conditions.
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • June 18th, 2015 • Gensight Biologics • Biological products, (no disgnostic substances) • Basel-Stadt
Contract Type FiledJune 18th, 2015 Company Industry JurisdictionThis Research Collaboration Agreement (the “Agreement”) having an Effective Date of March 1st, 2014, is made between the Friedrich Miescher Institute for Biomedical Research (“FMI”) located at Maulbeerstrasse 66, 4058 Basel, Switzerland, (Principal Investigator Dr. Botond Roska), and GenSight Biologics, located at 89 Rue du Fbg Saint Antoine, 75011 Paris, France (“GenSight”), (Principal Investigator Dr. Didier Pruneau), under the following terms and conditions.